Research Paper Volume 13, Issue 3 pp 4696—4712

Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma

Top 10 most frequently mutated genes in groups A–C of HCC patients with different prognostic impact. (A) Top 10 frequently mutated genes in group A (n = 10, recurrence within 6 months after LT). (B) Top 10 frequently mutated genes in group B (n = 10, non-recurrence for > 1 year after LT). (C) Top 10 frequently mutated genes in group C (n = 8, recurrence more than a year after LT).

Figure 2. Top 10 most frequently mutated genes in groups A–C of HCC patients with different prognostic impact. (A) Top 10 frequently mutated genes in group A (n = 10, recurrence within 6 months after LT). (B) Top 10 frequently mutated genes in group B (n = 10, non-recurrence for > 1 year after LT). (C) Top 10 frequently mutated genes in group C (n = 8, recurrence more than a year after LT).